Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 219.97 USD -0.3% Market Closed
Updated: May 17, 2024

Resmed Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Income from Continuing Operations Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Income from Continuing Operations
$958.4m
CAGR 3-Years
28%
CAGR 5-Years
16%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.3B
CAGR 3-Years
7%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
92%
CAGR 5-Years
0%
CAGR 10-Years
17%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.4B
CAGR 3-Years
34%
CAGR 5-Years
11%
CAGR 10-Years
16%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.6B
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2B
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
14%

See Also

What is Resmed Inc's Income from Continuing Operations?
Income from Continuing Operations
958.4m USD

Based on the financial report for Mar 31, 2024, Resmed Inc's Income from Continuing Operations amounts to 958.4m USD.

What is Resmed Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
11%

Over the last year, the Income from Continuing Operations growth was 11%. The average annual Income from Continuing Operations growth rates for Resmed Inc have been 28% over the past three years , 16% over the past five years , and 11% over the past ten years .